Plasmablastic Lymphoma Clinical Trials in Torino
3 recruitingTorino, Italy
Showing 1–3 of 3 trials
Recruiting
Phase 2
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
Plasmablastic Lymphoma
Fondazione Italiana Linfomi - ETS28 enrolled18 locationsNCT04915248
Recruiting
Phase 1
Study of SGR-1505 in Mature B-Cell Neoplasms
High-grade B-cell LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+23 more
Schrödinger, Inc.98 enrolled36 locationsNCT05544019
Recruiting
Study on Plasmablastic Lymphoma Patients
Plasmablastic Lymphoma
Fondazione Italiana Linfomi - ETS200 enrolled23 locationsNCT06781359